{"title":"A Multifaceted Intervention to Mitigate the Adverse Cardiovascular Effects of Air Pollution: A Feasibility Randomized Controlled Trial.","authors":"Parham Sadeghipour, Azita H Talasaz, Sina Rashedi, Sepehr Jamalkhani, Hamed Ghoshouni, Mohammadreza Babaei, Erfan Kohansal, Bahram Mohebbi, Armin Elahifar, Razieh Omidvar, Naser Hadavand, Mohammad Sadegh Hassanvand, Amirhoosein Poopak, Hooman Bakhshandeh, Saeideh Mazloomzadeh, Hessam Kakavand, Maryam Aghakouchakzadeh, Gregory Piazza, Harlan M Krumholz, Behnood Bikdeli","doi":"10.1097/FJC.0000000000001691","DOIUrl":null,"url":null,"abstract":"<p><p>Air pollution is associated with excess thrombotic and cardiovascular events. However, clinical outcomes trials evaluating interventions to mitigate such adverse events in patients with atherosclerotic cardiovascular diseases (ASCVD) are lacking. This is a single-center, open-label, feasibility randomized controlled trial (RCT) conducted in adult patients with documented ASCVD. Participants were randomized to a hybrid strategy consisting of an educational flashcard, educational cell phone text message alerts on polluted days to stay indoors, use KN95 masks if they need to go outside, and to consume citrus fruits on polluted days, versus usual care. The main objectives were to assess the feasibility of enrollment and adherence to and satisfaction with the hybrid strategy along with health-related quality of life and anxiety level. Between January 28, 2024, and February 18, 2024, 130 patients were screened, of whom 50 (38.5%) were randomized. During the study period, 12 polluted days occurred, and patients received a median of 8 ((IQR) 8 to 10) alerts. The majority adhered to all components on all polluted days, including full adherence for reading flashcards in 56%, avoiding outdoor activities in 52%, wearing KN-95 facemasks if they went out in 81.8%, and self-reported citrus fruit consumption in 84% of enrollees. The most participants in the intervention arm were satisfied with all components of the hybrid staretgy. Quality of life index and anxiety level remained unchanged for both groups during the 30-day follow-up. This pilot study shows the feasibility of recruitment to multifaceted strategy to mitigate the cardiovascular effects of air pollution with high adherence and satisfaction, thus supporting initiatives to design and conduct a large-scale RCT to validate and extend these findings.</p>","PeriodicalId":15212,"journal":{"name":"Journal of Cardiovascular Pharmacology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/FJC.0000000000001691","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Air pollution is associated with excess thrombotic and cardiovascular events. However, clinical outcomes trials evaluating interventions to mitigate such adverse events in patients with atherosclerotic cardiovascular diseases (ASCVD) are lacking. This is a single-center, open-label, feasibility randomized controlled trial (RCT) conducted in adult patients with documented ASCVD. Participants were randomized to a hybrid strategy consisting of an educational flashcard, educational cell phone text message alerts on polluted days to stay indoors, use KN95 masks if they need to go outside, and to consume citrus fruits on polluted days, versus usual care. The main objectives were to assess the feasibility of enrollment and adherence to and satisfaction with the hybrid strategy along with health-related quality of life and anxiety level. Between January 28, 2024, and February 18, 2024, 130 patients were screened, of whom 50 (38.5%) were randomized. During the study period, 12 polluted days occurred, and patients received a median of 8 ((IQR) 8 to 10) alerts. The majority adhered to all components on all polluted days, including full adherence for reading flashcards in 56%, avoiding outdoor activities in 52%, wearing KN-95 facemasks if they went out in 81.8%, and self-reported citrus fruit consumption in 84% of enrollees. The most participants in the intervention arm were satisfied with all components of the hybrid staretgy. Quality of life index and anxiety level remained unchanged for both groups during the 30-day follow-up. This pilot study shows the feasibility of recruitment to multifaceted strategy to mitigate the cardiovascular effects of air pollution with high adherence and satisfaction, thus supporting initiatives to design and conduct a large-scale RCT to validate and extend these findings.
期刊介绍:
Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke, kidney disease, lipid disorders, diabetes, systemic and pulmonary hypertension, cancer angiogenesis, neural and hormonal control of the circulation, sepsis, neurodegenerative diseases with a vascular component, cardiac and vascular remodeling, heart failure, angina, anticoagulants/antiplatelet agents, drugs/agents that affect vascular smooth muscle, and arrhythmias.
Appropriate subjects include new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects, application of drugs to gain novel insights into physiology or pathological conditions, clinical results with new and established agents, and novel methods. The focus is on pharmacology in its broadest applications, incorporating not only traditional approaches, but new approaches to the development of pharmacological agents and the prevention and treatment of cardiovascular diseases. Please note that JCVP does not publish work based on biological extracts of mixed and uncertain chemical composition or unknown concentration.